# Petra Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/petra-pharma

- Industry: Pharmaceuticals
- Headquarters: New York, US
- Website: www.petrapharmacorp.com
- Total disclosed funding: $48M
- Latest round: Series A (Dec 1, 2015)
- Investors on record: 12

## About

Founded in 2015 and based in New York, US, Petra Pharma Corp. operates as a developer of small molecule inhibitors for the treatment of cancer and metabolic diseases.

## Funding rounds

- Series A, Dec 1, 2015, $48M — ARCH Venture Partners, Alexandria Venture Investments, Johnson & Johnson Innovation, 180 Degree Capital, Pfizer Venture Investments, AbbVie Ventures, Accelerator Life Science Partners, Eli Lilly & Company, Partnership Fund for New York City, Watson Group Investments, SCP Buffalo Incubator Innovate NY Fund LP, Wuxi AppTec Group

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series A
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series A
- 180 Degree Capital (https://capitalatlas.ai/funds/180-degree-capital) — Series A
- Pfizer Venture Investments (https://capitalatlas.ai/funds/pfizer-venture-investments) — Series A
- AbbVie Ventures (https://capitalatlas.ai/funds/abbvie-ventures) — Series A
- Accelerator Life Science Partners (https://capitalatlas.ai/funds/accelerator-life-science-partners) — Series A
- Eli Lilly & Company — Series A
- Partnership Fund for New York City (https://capitalatlas.ai/funds/partnership-fund-for-new-york-city) — Series A
- Watson Group Investments (https://capitalatlas.ai/funds/watson-group-investments) — Series A
- SCP Buffalo Incubator Innovate NY Fund LP — Series A
- Wuxi AppTec Group — Series A